Conclusions: To our knowledge, this is the first long-term actigraphic documentation of sleep–wake behavior and response to modafinil in BTL. Treatment with modafinil was associated with the emergence of dose-dependend circadian disruption, recommending the use of very low dosages in treating hypersomnia in BTL. (Source: Clinical Neurophysiology)